The proportion of patients, PFS, and OS, according to the MIPI-c from the European MCL Network Younger and Elderly Trials
| Original MIPI . | Ki-67 index, % . | MIPI-c score . | Percentage . | Median PFS, y . | Median OS, y . |
|---|---|---|---|---|---|
| Low risk | <30 | Low risk | 32 | 7.4 | Not reached |
| >30 | Low-intermediate risk | 34 | 4.4 | Not reached | |
| Intermediate risk | <30 | ||||
| >30 | High-intermediate risk | 23 | 2.0 | 4.3 | |
| High risk | <30 | ||||
| >30 | High risk | 11 | 1 | 1.5 |
| Original MIPI . | Ki-67 index, % . | MIPI-c score . | Percentage . | Median PFS, y . | Median OS, y . |
|---|---|---|---|---|---|
| Low risk | <30 | Low risk | 32 | 7.4 | Not reached |
| >30 | Low-intermediate risk | 34 | 4.4 | Not reached | |
| Intermediate risk | <30 | ||||
| >30 | High-intermediate risk | 23 | 2.0 | 4.3 | |
| High risk | <30 | ||||
| >30 | High risk | 11 | 1 | 1.5 |
Adapted from Hoster et al14 with additional data provided by Dr. Hoster.
MIPI-c, combined Mantle Cell International Prognostic Index.